These findings align with preclinical data, as noted in Section 3.4, which indicates that polyphenols (e.g., EGCG, curcumin) reduce tumor angiogenesis through AT1R inhibition, while Section 4.1 highlights their ability to modulate the tumor microenvironment by decreasing oxidative stress and inflammation [38,39]. Here, AGTR1 is linked to neoplasm.